Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Barbara

Showing results (71-80 of 131) with videos related to

Pageof 14
Sort By:
BMJ (Clinical Research Ed.)|March 12, 1994
Follow up of blood donors positive for antibodies to hepatitis C virusK E Ryan, S MacLennan, J A Barbara, et al.
Lancet (London, England)|January 11, 1992
Screening blood donations for HCVS Maclennan, J A Barbara, P Hewitt, et al.
Vox Sanguinis|July 14, 2001
Human T-cell leukaemia/lymphoma virus risk may be enhanced in some selected donor populationsJ Price, B A Cant, J A Barbara, et al.
British Medical Journal (Clinical Research Ed.)|March 9, 1985
Blood donors at high risk of transmitting the acquired immune deficiency syndromeM Contreras, P E Hewitt, J A Barbara, et al.
Transfusion Medicine (Oxford, England)|December 1, 1991
Is there a wastage of resources due to non-specificity of anti-HIV ELISAs?M A Rodriguez, J Runganga, M Contreras, et al.
Vox Sanguinis|January 1, 1997
Does anti-HBc reactivity reflect 'lifestyle' risk in north London blood donors?M C Moore, G S Godfrey, P E Hewitt, et al.
Clinical Nephrology|July 4, 2001
Relationships between homocysteine and related amino acids in chronic hemodialysis patientsS P McDonald, M J Whiting, G A Tallis, et al.
Transfusion Medicine (Oxford, England)|June 3, 1999
Prevention of transfusion-transmitted cytomegalovirus infectionD H Pamphilon, J R Rider, J A Barbara, et al.
Journal of Internal Medicine|October 24, 2007
Acute effects of haemodialysis on biochemical modulators of endothelial functionC L Hewitson, M J Whiting, J A Barbara, et al.
Transfusion Medicine (Oxford, England)|March 1, 1996
Reducing risks in blood transfusion: process and outcomeD B McClelland, J J McMenamin, H M Moores, et al.
Pageof 14

Showing results (71-80 of 131) with videos related to

Sort By:
Pageof 14
BMJ (Clinical Research Ed.)|March 12, 1994
Follow up of blood donors positive for antibodies to hepatitis C virusK E Ryan, S MacLennan, J A Barbara, et al.
Lancet (London, England)|January 11, 1992
Screening blood donations for HCVS Maclennan, J A Barbara, P Hewitt, et al.
Vox Sanguinis|July 14, 2001
Human T-cell leukaemia/lymphoma virus risk may be enhanced in some selected donor populationsJ Price, B A Cant, J A Barbara, et al.
British Medical Journal (Clinical Research Ed.)|March 9, 1985
Blood donors at high risk of transmitting the acquired immune deficiency syndromeM Contreras, P E Hewitt, J A Barbara, et al.
Transfusion Medicine (Oxford, England)|December 1, 1991
Is there a wastage of resources due to non-specificity of anti-HIV ELISAs?M A Rodriguez, J Runganga, M Contreras, et al.
Vox Sanguinis|January 1, 1997
Does anti-HBc reactivity reflect 'lifestyle' risk in north London blood donors?M C Moore, G S Godfrey, P E Hewitt, et al.
Clinical Nephrology|July 4, 2001
Relationships between homocysteine and related amino acids in chronic hemodialysis patientsS P McDonald, M J Whiting, G A Tallis, et al.
Transfusion Medicine (Oxford, England)|June 3, 1999
Prevention of transfusion-transmitted cytomegalovirus infectionD H Pamphilon, J R Rider, J A Barbara, et al.
Journal of Internal Medicine|October 24, 2007
Acute effects of haemodialysis on biochemical modulators of endothelial functionC L Hewitson, M J Whiting, J A Barbara, et al.
Transfusion Medicine (Oxford, England)|March 1, 1996
Reducing risks in blood transfusion: process and outcomeD B McClelland, J J McMenamin, H M Moores, et al.
Pageof 14